Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Brainsway Ltd. Regulatory Filings 2021

Oct 6, 2021

33354_rns_2021-10-06_e34d4894-d469-47ff-aa67-43ac19b6183b.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm

Brainsway Ltd. 19 Hartum Street Bynet Building, 3rd Floor Har HaHotzvim Jerusalem, 9777518, Israel

October 6, 2021

By EDGAR

United States Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E.

Washington, D.C. 20549

RE:
Registration Statement on Form F-3
Filed September 17, 2021
File No. 333-259610

Ladies and Gentlemen:

Pursuant to Rules 460 and 461 of the Rules and Regulations of the Securities and Exchange Commission (the “ Commission ”) under the Securities Act of 1933, as amended, Brainsway Ltd. (the “ Company ”) hereby requests acceleration of the effective date of the above-mentioned Registration Statement on Form F-3 to 4:00 p.m., Eastern Time on October 8, 2021, or as soon thereafter as practicable.

Should any member of the staff of the U.S. Securities and Exchange Commission have any questions or comments with respect to this request, please contact our counsel, Gross & Co., attention: Oded Bejarano at (972) 3-6074547.

Very truly yours,
Brainsway Ltd.
By: /s/ Scott Areglado
Scott Areglado
Senior Vice President and Chief Financial Officer